98.1/160
Price confirmed weakness (0.00% since peak score date, -16.90% from recent high).
- Main score
- 56.1/110
- 5D momentum v2
- 42/50
- 1D
- +13.41%
- Median
- -1.53%
- Win rate
- 30%
- Down5
- 17.5%
指數排名
排名 · 160 分制
| Action | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #1 US.CCL Carnival Corporation | 98.1 | 56.1 /110 | 42 /50 | -1.53% | 30% | 17.5% | Med | Consumer Discretionary | $25.11 +13.41% | $1.89B 75.3M shares | Healthy | View | |
| #2 US.NTAP NetApp | 87.8 | 61.8 /110 | 26 /50 | -0.01% | 50% | 15% | Elev | Information Technology | $209.18 +2.33% | $551.35M 2.6M shares | Healthy | View | |
| #3 US.AMAT Applied Materials | 87.5 | 60.5 /110 | 27 /50 | -0.32% | 47.5% | 17.5% | Elev | Information Technology | $512.01 +5.19% | $3.65B 7.1M shares | Healthy | View | |
| #4 US.TXN Texas Instruments | 84.6 | 65.6 /110 | 19 /50 | -0.05% | 50% | 17.5% | Med | Information Technology | $281.69 +1.21% | $1.41B 5M shares | Healthy | View | |
| #5 US.MRNA Moderna | 84.2 | 52.2 /110 | 32 /50 | 0.49% | 57.5% | 17.5% | Elev | Health Care | $203.46 +3.13% | $2.66B 13.1M shares | Watch | View | |
| #6 US.KLAC KLA Corporation | 83 | 63 /110 | 20 /50 | 0.25% | 52.5% | 17.5% | Elev | Information Technology | $196.53 +3.89% | $1.53B 7.8M shares | Healthy | View | |
| #7 US.ZBRA Zebra Technologies | 82.6 | 59.6 /110 | 23 /50 | 0.14% | 55% | 17.5% | Med | Information Technology | $375.97 +1.10% | $222.03M 590.6K shares | Watch | View | |
| #8 US.LRCX Lam Research | 80 | 59 /110 | 21 /50 | -0.27% | 45% | 12.5% | Elev | Information Technology | $323.86 +2.99% | $2.54B 7.8M shares | Watch | View | |
| #9 US.RCL Royal Caribbean Group | 79.4 | 58.4 /110 | 21 /50 | 0.52% | 57.5% | 12.5% | Elev | Consumer Discretionary | $260.67 +7.45% | $1.05B 4M shares | Watch | View | |
| #10 US.RVTY Revvity | 79.4 | 54.4 /110 | 25 /50 | 0.82% | 60% | 0% | Elev | Health Care | $152.77 +1.16% | $241.79M 1.6M shares | Watch | View | |
| #11 US.ADI Analog Devices | 76.6 | 61.6 /110 | 15 /50 | 0.55% | 57.5% | 10% | Med | Information Technology | $398.22 +0.71% | $973.48M 2.4M shares | Watch | View | |
| #12 US.MAR Marriott International | 76.5 | 54.5 /110 | 22 /50 | -1.38% | 37.5% | 10% | Med | Consumer Discretionary | $361.62 +0.85% | $525.29M 1.5M shares | Watch | View | |
| #13 US.AMGN Amgen | 75.8 | 62.8 /110 | 13 /50 | 0.09% | 52.5% | 7.5% | Med | Health Care | $423.64 +1.32% | $1.46B 3.4M shares | Watch | View | |
| #14 US.TER Teradyne | 74.9 | 57.9 /110 | 17 /50 | 0.96% | 62.5% | 15% | Elev | Information Technology | $403.02 +0.43% | $882.26M 2.2M shares | Watch | View | |
| #15 US.HLT Hilton Worldwide | 74 | 55 /110 | 19 /50 | -1.31% | 42.5% | 12.5% | Med | Consumer Discretionary | $323.44 +0.99% | $460.10M 1.4M shares | Watch | View | |
| #16 US.TT Trane Technologies | 74 | 63 /110 | 11 /50 | 1.25% | 72.5% | 2.5% | Med | Industrials | $455.59 +0.78% | $538.40M 1.2M shares | Watch | View | |
| #17 US.KR Kroger | 73.6 | 58.6 /110 | 15 /50 | -1.59% | 30% | 0% | Med | Consumer Staples | $60.79 +1.84% | $630.26M 10.4M shares | Watch | View | |
| #18 US.LITE Lumentum | 73.5 | 60.5 /110 | 13 /50 | 0.16% | 55% | 17.5% | Elev | Information Technology | $973.49 +5.66% | $5.86B 6M shares | Watch | View | |
| #19 US.TJX TJX Companies | 73.5 | 60.5 /110 | 13 /50 | -0.47% | 45% | 12.5% | Med | Consumer Discretionary | $133.80 +2.73% | $1.49B 11.2M shares | Watch | View | |
| #20 US.CAT Caterpillar Inc. | 72.5 | 63.5 /110 | 9 /50 | 0.78% | 60% | 2.5% | Med | Industrials | $826.64 +0.82% | $1.82B 2.2M shares | Watch | View | |
| #21 US.VTRS Viatris | 72.5 | 57.5 /110 | 15 /50 | 0.04% | 52.5% | 5% | Med | Health Care | $18.12 -0.82% | $212.95M 11.8M shares | Watch | View | |
| #22 US.PLTR Palantir Technologies | 72.3 | 65.3 /110 | 7 /50 | 0.56% | 62.5% | 2.5% | Med | Information Technology | $186.97 -0.27% | $2.64B 14.1M shares | Deteriorating | View | |
| #23 US.HUBB Hubbell Incorporated | 72 | 63 /110 | 9 /50 | 0.16% | 52.5% | 0% | Med | Industrials | $459.09 -1.42% | $228.52M 497.8K shares | Deteriorating | View | |
| #24 US.PANW Palo Alto Networks | 70.8 | 59.8 /110 | 11 /50 | 0.08% | 50% | 7.5% | Elev | Information Technology | $388.41 -0.94% | $1.98B 5.1M shares | Watch | View | |
| #25 US.IDXX Idexx Laboratories | 70.7 | 61.7 /110 | 9 /50 | -1.53% | 32.5% | 10% | Med | Health Care | $533.44 +0.83% | $345.77M 648.2K shares | Deteriorating | View | |
| #26 US.KEYS Keysight Technologies | 70.7 | 61.7 /110 | 9 /50 | 0.49% | 60% | 5% | Med | Information Technology | $360.65 +0.25% | $317.76M 881.1K shares | Watch | View | |
| #27 US.ALLE Allegion | 70.4 | 65.4 /110 | 5 /50 | 1.49% | 67.5% | 5% | Med | Industrials | $155.43 +0.03% | $175.00M 1.1M shares | Watch | View | |
| #28 US.GRMN Garmin | 70.3 | 59.3 /110 | 11 /50 | -0.22% | 45% | 7.5% | Med | Consumer Discretionary | $290.23 -1.30% | $273.92M 943.8K shares | Deteriorating | View | |
| #29 US.IR Ingersoll Rand | 70.1 | 59.1 /110 | 11 /50 | 0.41% | 60% | 0% | Med | Industrials | $76.48 +0.13% | $370.98M 4.9M shares | Deteriorating | View | |
| #30 US.NVDA Nvidia | 69.9 | 66.9 /110 | 3 /50 | 0.19% | 50% | 10% | Med | Information Technology | $227.21 -0.72% | $22.32B 98.2M shares | Watch | View |
98.1/160
Price confirmed weakness (0.00% since peak score date, -16.90% from recent high).
87.8/160
Score declined in 3 of the last 5 intervals.
87.5/160
Price confirmed weakness (0.00% since peak score date, -18.70% from recent high).
84.6/160
Momentum weakened by -2.0 with 3 recent down snapshots.
84.2/160
Momentum weakened by -15.0 with 3 recent down snapshots.
83/160
Price confirmed weakness (+5.00% since peak score date, -20.60% from recent high).
82.6/160
Total score fell from 112.7 to 82.6 (-30.1).
80/160
Momentum weakened by -10.0 with 4 recent down snapshots.
79.4/160
Price confirmed weakness (-19.20% since peak score date, -22.00% from recent high).
79.4/160
Total score fell from 108.2 to 79.4 (-28.8).
76.6/160
Total score fell from 91.6 to 76.6 (-15.0).
76.5/160
Total score fell from 87.9 to 76.5 (-11.4).
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.